课题基金 / 基金详情

Genetic Elucidation of AMP-Activated Protein Kinase Signaling Mechanisms

Genetic Elucidation of AMP-Activated Protein Kinase Signaling Mechanisms
AMP 激活蛋白激酶信号传导机制的遗传阐明
批准号:
8988602
负责人:
JAY BRENMAN
金额:
$28.83万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-12-01 至 2017-12-31

项目摘要

项目成果

JAY BRENMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract: AMP-activated protein kinase (AMPK) functions as a key energy sensor and metabolic rheostat to maintain cells' energy needs, largely through maintaining ATP levels. Disruption of AMPK signaling leads to neuronal death, while mutations in human AMPK subunits cause the fatal cardiac disorder, Wolff-Parkinson-White syndrome. We are using a genetic model in Drosophila to identify genes that modulate AMPK signaling in vivo. Using this novel forward genetic screen we have identified nucleoside diphosphate kinase (NDPK) as a potential modifier and target of AMPK signaling. We have found a new mechanism whereby AMPK-dependent phsphorylation of NDPK turns it off. This off switch site corresponds to a location mutated in advanced human neuroblastoma. Through identification of new genes that suppress AMPK RNAi lethality, and making a genetic model of mutations in AMPK that cause human disease, we hope to identify both new mechanisms and molecules that modulate AMPK function in vivo.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.pharmthera.2014.02.008
发表时间: 2014-07
期刊: PHARMACOLOGY & THERAPEUTICS
影响因子: 13.5
作者: [Sinnett, Sarah E., Brenman, Jay E.]
通讯作者: Brenman, Jay E.
DOI: 10.1007/978-3-319-43589-3_16
发表时间: 2016
期刊: Experientia supplementum (2012)
影响因子: --
作者: [Sinnett SE, Brenman JE]
通讯作者: Brenman JE
DOI: 10.4137/jen.s25475
发表时间: 2015
期刊: Journal of experimental neuroscience
影响因子: --
作者: [Onyenwoke RU, Brenman JE]
通讯作者: Brenman JE
DOI: 10.1534/genetics.113.151639
发表时间: 2013-09
期刊: Genetics
影响因子: 3.3
作者: [Kern JV, Zhang YV, Kramer S, Brenman JE, Rasse TM]
通讯作者: Rasse TM
Modulation of dendritic spiking in vivo
High-Content Screening for Peroxisome Biogenesis for Type-II Diabetes.
High-Content Screening for Peroxisome Biogenesis for Type-II Diabetes.
High-Content Screening for Peroxisome Biogenesis for Type-II Diabetes.
海外基金